Either loss-of-function mutations of SPOP or gain-of-function mutations of PDK1 in their binding region all attenuate SPOP recognizing and ubiquitinating PDK1, leading to elevat PDK1 protein abundance, AKT kinase activity and benefit of tumor malignancies. This evidence concerns the gene SPOP and neoplasm.